✦ LIBER ✦

Effect of Alendronate in Postmenopausal Women with Low Bone Mass - 18 Months Results

✍ Scribed by Galesanu, Corina; Galesanu, Mihai Romeo; Florescu, Alexandru; Grozavu, Ilinka; Assistant, Valentin Zaharia; Assistant, Adrian Aancute

Book ID: 122505637
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 134 KB
Volume: 13
Category: Article
ISSN: 1094-6950
DOI: 10.1016/j.jocd.2010.01.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of denosumab and alendronate at

Effects of denosumab and alendronate at the ultradistal radius in postmenopausal women with low bone mass

✍ E. Seeman; T. Thomas; S.K. Boyd; S. Boutroy; E. Shane; D.A. Hanley; C. Bogado; A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Comparative effects of raloxifene and al

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

✍ Robert R. Recker; David Kendler; Christopher P. Recknor; Theodore W. Rooney; E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 265 KB

The double-blind, randomized raloxifene alendronate comparison trial was the first study designed to compare two osteoporosis therapies head-to-head for fracture risk reduction. The original protocol planned to treat 3000 postmenopausal women with alendronate 10 mg/day (ALN) or raloxifene 60 mg/day

Biological Effects of Supplementation wi

Biological Effects of Supplementation with Vitamin D and Calcium in Postmenopausal Women with Low Bone Mass Receiving Alendronate

✍ Michel Brazier, S. Kamel, F. Lorget, M. Maamer, C. Tavera, N. Heurtebize, F. Gra 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 121 KB

Short-term effect of alendronate on bone

Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women

✍ C. H. Chesnut; S. T. Harris 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 333 KB

Denosumab and Alendronate Have Different

Denosumab and Alendronate Have Different Effects at the Ultradistal Radius in Postmenopausal Women With Low Bone Mass

✍ Cesar Libanati; Ego Seeman; Thierry Thomas; Steven Boyd; Stephanie Boutroy; Eliz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Odanacatib treatment in postmenopausal w

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

✍ M. McClung; J.A. Eisman; H.G. Bone; C. Roux; R.R. Recker; N. Verbruggen; C.M. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB